Nakade S , Tsubota T , Sakane Y , Kume S , Sakamoto N , Obara M , Daimon T , Sezutsu H , Yamamoto T , Sakuma T , Suzuki KT .

	Figure 1. TAL-PITCh in human cells.(a) Schematic illustration of TAL-PITCh at the human FBL locus. Orange and pink letters indicate the left and right TALEN target sites, respectively. Red and blue boxes indicate the microhomologous sequences. The stop codon is underlined. (b) Sequences of knocked-in clones. The intended knocked-in sequence is shown at the top. TALEN target sites are shown in capital letters. Red letters indicate correctly knocked-in clones. (c) Confocal laser scanning microscopy image of knocked-in cells showing nucleolar localization of mNeonGreen fluorescence (clone #H6). Scale bar, 30 μm.
	Figure 2. TAL-PITCh in silkworms.(a) Schematic illustration of TAL-PITCh at the B. mori BLOS2 locus. Orange and pink letters indicate the left and right TALEN target sites, respectively. Red and blue boxes indicate the microhomologous sequences. hsp90P, hsp90 promoter. (b) Sequences of knocked-in alleles from the six G1 worms (#2–1, #5–1, #5–9, #5–10, #7–6 and #7–7). The intended knocked-in sequence is shown at the top. TALEN target sites are shown in capital letters. Red letters indicate correctly knocked-in alleles. Blue letters indicate insertions. (c) Bright-field and fluorescence microscopy images of the G1 embryos in the #5 batch. Strong EGFP expression could be observed in the putative knock-in embryo, according to the activity of the hsp90 promoter (arrowhead). Scale bar, 0.5 mm. (d) Bright-field and fluorescence microscopy images of the G2 larva derived from #5–9 batch. White and yellow arrowheads indicate wild-type and knock-in silkworms, respectively. Note that the knock-in larva shows an oily skin phenotype. Scale bar, 1 mm.
	Figure 3. TAL-PITCh at the no29 locus in frog embryos.(a) Schematic illustration of TAL-PITCh at the X. laevis no29 locus. Orange and pink letters indicate the left and right TALEN target sites, respectively. Red and blue boxes indicate the microhomologous sequences. The start codons are underlined. (b) Sequences of knocked-in alleles from embryo #9. The intended knocked-in sequence is shown at the top. TALEN target sites are shown in capital letters. Red letters indicate correctly knocked-in alleles. Blue letters indicate insertions. Dashes indicate deletions. Substitutions are underlined. (c) Bright-field and fluorescence microscopy images of embryo #9. An asterisk indicates yolk autofluorescence. Scale bar, 1 mm. (d) Percentage of phenotypes in the control embryos and the TAL-PITChed embryos. For the control, the vector from which the TALEN target site was removed was used instead of the TAL-PITCh vector. Except for abnormally developed embryos, phenotypes were divided into four groups (full, half, ectopic and normal) according to the expressed region of EGFP. Total numbers of individuals are shown at the top of each graph.
	Figure 4. TAL-PITCh at the fgk locus in frog embryos.(a) Schematic illustration of TAL-PITCh at the X. laevis fgk locus. Orange and pink letters indicate the left and right TALEN target sites, respectively. Red and blue boxes indicate the microhomologous sequences. The stop codon is underlined. (b,c) Microscopic images and sequences of the TAL-PITChed embryos showing EGFP expression in the fin (b) and the gill (c). TALEN target sites are shown in capital letters. Red letters indicate correctly knocked-in alleles. Substitutions are underlined. Scale bars, 1 mm.
	Figure 5. CRIS-PITCh in human cells.(a) Schematic illustration of CRISPR/Cas9-mediated targeted integration using CRIS-PITCh. Orange, pink and green letters indicate the gRNA target sites. Red and blue boxes indicate the microhomologous sequences. The stop codons are underlined. (b) Sequences of knocked-in clones. The intended knocked-in sequence is shown at the top. Dashes indicate deletions. Blue letters indicate the insertion. The substitution is underlined. (c) Confocal laser scanning microscopy image of knocked-in cells showing nucleolar localization of mNeonGreen fluorescence (clone #B4). Scale bar, 30 μm.

Auer, Highly efficient CRISPR/Cas9-mediated knock-in in zebrafish by homology-independent DNA repair. 2014, Pubmed

Auer, Highly efficient CRISPR/Cas9-mediated knock-in in zebrafish by homology-independent DNA repair. 2014, Pubmed
Bae, Microhomology-based choice of Cas9 nuclease target sites. 2014, Pubmed
Carroll, Genome engineering with targetable nucleases. 2014, Pubmed
Cermak, Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting. 2011, Pubmed
Chen, High-frequency genome editing using ssDNA oligonucleotides with zinc-finger nucleases. 2011, Pubmed
Cradick, CRISPR/Cas9 systems targeting β-globin and CCR5 genes have substantial off-target activity. 2013, Pubmed
Cristea, In vivo cleavage of transgene donors promotes nuclease-mediated targeted integration. 2013, Pubmed
Daimon, Recent progress in genome engineering techniques in the silkworm, Bombyx mori. 2014, Pubmed
Doyon, Enhancing zinc-finger-nuclease activity with improved obligate heterodimeric architectures. 2011, Pubmed
Fine, An online bioinformatics tool predicts zinc finger and TALE nuclease off-target cleavage. 2014, Pubmed
Fu, High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. 2013, Pubmed
Hockemeyer, Genetic engineering of human pluripotent cells using TALE nucleases. 2011, Pubmed
Hockemeyer, Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases. 2009, Pubmed
Hsu, DNA targeting specificity of RNA-guided Cas9 nucleases. 2013, Pubmed
Kay, A robust system for production of minicircle DNA vectors. 2010, Pubmed
Kim, A guide to genome engineering with programmable nucleases. 2014, Pubmed
Maresca, Obligate ligation-gated recombination (ObLiGaRe): custom-designed nuclease-mediated targeted integration through nonhomologous end joining. 2013, Pubmed
McVey, MMEJ repair of double-strand breaks (director's cut): deleted sequences and alternative endings. 2008, Pubmed
Miller, A TALE nuclease architecture for efficient genome editing. 2011, Pubmed
Miller, An improved zinc-finger nuclease architecture for highly specific genome editing. 2007, Pubmed
Miyaoka, Isolation of single-base genome-edited human iPS cells without antibiotic selection. 2014, Pubmed
Motoi, Spatiotemporal expression profile of no29/nucleophosmin3 in the intestine of Xenopus laevis during metamorphosis. 2011, Pubmed , Xenbase
Ochiai, TALEN-mediated single-base-pair editing identification of an intergenic mutation upstream of BUB1B as causative of PCS (MVA) syndrome. 2014, Pubmed
Orlando, Zinc-finger nuclease-driven targeted integration into mammalian genomes using donors with limited chromosomal homology. 2010, Pubmed
Sakane, Targeted mutagenesis of multiple and paralogous genes in Xenopus laevis using two pairs of transcription activator-like effector nucleases. 2014, Pubmed , Xenbase
Sakuma, Multiplex genome engineering in human cells using all-in-one CRISPR/Cas9 vector system. 2014, Pubmed
Sakuma, Repeating pattern of non-RVD variations in DNA-binding modules enhances TALEN activity. 2013, Pubmed , Xenbase
Shaner, A bright monomeric green fluorescent protein derived from Branchiostoma lanceolatum. 2013, Pubmed
Suzuki, Characterization of a novel type I keratin gene and generation of transgenic lines with fluorescent reporter genes driven by its promoter/enhancer in Xenopus laevis. 2010, Pubmed , Xenbase
Suzuki, High efficiency TALENs enable F0 functional analysis by targeted gene disruption in Xenopus laevis embryos. 2013, Pubmed , Xenbase
Szczepek, Structure-based redesign of the dimerization interface reduces the toxicity of zinc-finger nucleases. 2007, Pubmed
Takasu, Efficient TALEN construction for Bombyx mori gene targeting. 2013, Pubmed
Taleei, Biochemical DSB-repair model for mammalian cells in G1 and early S phases of the cell cycle. 2013, Pubmed
Tsubota, Identification of a novel strong and ubiquitous promoter/enhancer in the silkworm Bombyx mori. 2014, Pubmed